Antimicrobial Wound Dressings Market Segmentation:
Application (Chronic Wounds, Acute Wounds)
The chronic wounds segment in the antimicrobial wound dressings market is set to account for 58% revenue share by 2035. The dominance can be linked to an increase in the number of persons suffering from chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types. Diabetes, cancer, and other autoimmune illnesses are expected to increase the incidence rate of chronic wounds all over the world. Diabetes risk factors include age, diet, physical activity, obesity, and genetics.
High blood sugar levels, poor circulation, immune system issues, and nerve damage can all increase the risk of developing a chronic wound, such as a diabetic foot ulcer. For instance, approximately 25% of patients with diabetes will develop a foot ulcer. A foot ulcer is the starting point for 85% of diabetic amputations. Also, neuropathy, peripheral arterial disease (PAD), deformities, and Charcot's foot are all risk factors for developing diabetic foot ulcers.
Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings)
The silver dressings segment is predicted to hold a substantial share of 50% during the forecast timeline. The segment growth is driven by growing demand for the treatment of infections and wounds. Silver wound dressings are antimicrobial wound dressings using silver as an active ingredient. The dressing acts by releasing silver ions, which help to kill or inhibit the development of bacteria in the wound bed. In the treatment of chronic wounds that are prone to infection, such as pressure ulcers and diabetic foot ulcers, silver wound dressing is helpful. They are also used to treat surgical wounds, lowering the risk of infection and promoting speedier recovery.
Our in-depth analysis of the market includes the following segments:
|
Product |
|
|
Application |
|
|
End-use |
|
